Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_assertion type Assertion NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_head.
- NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_assertion description "[Substance P autocrine signaling contributes to persistent HER2 activation that drives malignant progression and drug resistance in breast cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_provenance.
- NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_assertion evidence source_evidence_literature NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_provenance.
- NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_assertion SIO_000772 24030979 NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_provenance.
- NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_assertion wasDerivedFrom befree-2016 NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_provenance.
- NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_assertion wasGeneratedBy ECO_0000203 NP1110102.RAxBzcoqmaihE1jEYWNMI4CZcrWjaP41ddBeHKvlXNC_I130_provenance.